• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物材料增强的细胞和药物递送:心脏领域的经验教训和未来展望。

Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.

机构信息

Tissue Engineering Research Group (TERG), Department of Anatomy, Royal College of Surgeons in Ireland (RSCI), 123, St. Stephens Green, Dublin 2, Dublin, D02 YN77, Ireland.

Trinity Center for Bioengineering (TCBE), Trinity College Dublin, Dublin 2, Dublin, Ireland.

出版信息

Adv Mater. 2016 Jul;28(27):5648-61. doi: 10.1002/adma.201505349. Epub 2016 Feb 3.

DOI:10.1002/adma.201505349
PMID:26840955
Abstract

Heart failure is a significant clinical issue. It is the cause of enormous healthcare costs worldwide and results in significant morbidity and mortality. Cardiac regenerative therapy has progressed considerably from clinical and preclinical studies delivering simple suspensions of cells, macromolecule, and small molecules to more advanced delivery methods utilizing biomaterial scaffolds as depots for localized targeted delivery to the damaged and ischemic myocardium. Here, regenerative strategies for cardiac tissue engineering with a focus on advanced delivery strategies and the use of multimodal therapeutic strategies are reviewed.

摘要

心力衰竭是一个重大的临床问题。它是全球医疗保健成本巨大的原因,并导致了大量的发病率和死亡率。心脏再生疗法已经从临床和临床前研究中简单的细胞、大分子和小分子悬浮液发展到了更先进的输送方法,利用生物材料支架作为受损和缺血性心肌局部靶向输送的储存库。在这里,我们重点介绍了先进的输送策略和多模式治疗策略在心脏组织工程中的再生策略。

相似文献

1
Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.生物材料增强的细胞和药物递送:心脏领域的经验教训和未来展望。
Adv Mater. 2016 Jul;28(27):5648-61. doi: 10.1002/adma.201505349. Epub 2016 Feb 3.
2
Application of Cell, Tissue, and Biomaterial Delivery in Cardiac Regenerative Therapy.细胞、组织和生物材料递送在心脏再生治疗中的应用。
ACS Biomater Sci Eng. 2021 Mar 8;7(3):1000-1021. doi: 10.1021/acsbiomaterials.0c01805. Epub 2021 Feb 16.
3
Drug and cell delivery for cardiac regeneration.药物和细胞递送促进心脏再生。
Adv Drug Deliv Rev. 2015 Apr;84:85-106. doi: 10.1016/j.addr.2014.08.006. Epub 2014 Aug 27.
4
Heart regeneration after myocardial infarction using synthetic biomaterials.心肌梗死后使用合成生物材料进行心脏再生。
J Control Release. 2015 Apr 10;203:23-38. doi: 10.1016/j.jconrel.2015.02.009. Epub 2015 Feb 7.
5
The Potential Application of Biomaterials in Cardiac Stem Cell Therapy.生物材料在心脏干细胞治疗中的潜在应用。
Curr Med Chem. 2016;23(6):589-602. doi: 10.2174/092986732306160303151041.
6
In vitro cardiac tissue models: Current status and future prospects.体外心脏组织模型:现状与未来展望。
Adv Drug Deliv Rev. 2016 Jan 15;96:203-13. doi: 10.1016/j.addr.2015.09.011. Epub 2015 Sep 30.
7
Biomatrices for Heart Regeneration and Cardiac Tissue Modelling In Vitro.用于心脏再生和心脏组织体外建模的生物基质
Adv Exp Med Biol. 2020;1298:43-77. doi: 10.1007/5584_2020_564.
8
Exploring and Exploiting Tissue Engineering Through the Design of Multifunctional Therapeutic Systems.探索和利用组织工程学通过多功能治疗系统的设计。
Curr Stem Cell Res Ther. 2019;14(2):80-82. doi: 10.2174/1574888X1402190218113533.
9
Delivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives.基于生物材料支架的核酸纳米药物在骨科组织修复中的应用:挑战、进展及未来展望。
Adv Mater. 2016 Jul;28(27):5447-69. doi: 10.1002/adma.201505088. Epub 2016 Feb 3.
10
Recent advance in delivery system and tissue engineering applications of chondroitin sulfate.硫酸软骨素的递送系统和组织工程应用的最新进展。
Carbohydr Polym. 2020 Feb 15;230:115650. doi: 10.1016/j.carbpol.2019.115650. Epub 2019 Nov 20.

引用本文的文献

1
Engineering functional electroconductive hydrogels for targeted therapy in myocardial infarction repair.用于心肌梗死修复靶向治疗的工程化功能性导电水凝胶
Bioact Mater. 2025 Mar 9;49:172-192. doi: 10.1016/j.bioactmat.2025.01.013. eCollection 2025 Jul.
2
Cross Talk Between Cells and the Current Bioceramics in Bone Regeneration: A Comprehensive Review.细胞间相互作用与当前用于骨再生的生物陶瓷:全面综述。
Cell Transplant. 2024 Jan-Dec;33:9636897241236030. doi: 10.1177/09636897241236030.
3
Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction.
细胞外基质/糖肽杂化水凝胶作为心肌梗死后内源性心脏修复的免疫调节小生境
Adv Sci (Weinh). 2023 Aug;10(23):e2301244. doi: 10.1002/advs.202301244. Epub 2023 Jun 15.
4
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.基于可注射水凝胶的治疗性血管生成用于缺血性心脏病中的蛋白质递送
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.
5
Injectable selenium-containing polymeric hydrogel formulation for effective treatment of myocardial infarction.用于有效治疗心肌梗死的可注射含硒聚合物水凝胶制剂
Front Bioeng Biotechnol. 2022 Jul 11;10:912562. doi: 10.3389/fbioe.2022.912562. eCollection 2022.
6
Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis.基于固化干细胞分泌组构建微粒,其具有增强的促血管生成因子组合用于治疗性血管生成。
Bioact Mater. 2022 Apr 2;17:526-541. doi: 10.1016/j.bioactmat.2022.03.015. eCollection 2022 Nov.
7
Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT.导电纳米复合水凝胶与间充质干细胞联合治疗心肌梗死及通过 PET/CT 实现无创监测
J Nanobiotechnology. 2022 May 6;20(1):211. doi: 10.1186/s12951-022-01432-7.
8
Biomaterials to enhance stem cell transplantation.生物材料增强干细胞移植。
Cell Stem Cell. 2022 May 5;29(5):692-721. doi: 10.1016/j.stem.2022.04.002. Epub 2022 Apr 27.
9
Chitosan as Functional Biomaterial for Designing Delivery Systems in Cardiac Therapies.壳聚糖作为用于心脏治疗中设计递送系统的功能性生物材料。
Gels. 2021 Dec 9;7(4):253. doi: 10.3390/gels7040253.
10
3D bioprinting in cardiac tissue engineering.三维生物打印在心脏组织工程中的应用。
Theranostics. 2021 Jul 6;11(16):7948-7969. doi: 10.7150/thno.61621. eCollection 2021.